Skip to main content
. 2011 Aug;28(1):115–124. doi: 10.1159/000331720

Fig. 5.

Fig. 5

IL-15-mediated activation of NFkB may involve p38MAPK/Akt pathways. RBE4 cells expressing an NFkB luciferase reporter were pretreated for 1 h with either Bay 11-7082 (Bay) or SB203580. Cells were then treated with either IL-15 (5 ng/ml) or TNF (5 ng/ml) for 6 h in the presence or absence of inhibitors. Data are presented as fold-induction of respective controls. *p < 0.05, ***p < 0.005.